Monza, Italy

Lucio C Rovati

USPTO Granted Patents = 57 

 

 

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 228(Granted Patents)

Forward Citations (Not Self Cited) = 217(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Milan, IT (2015)
  • Monza, IT (1988 - 2023)

Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
57 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Lucio C Rovati

Introduction

Lucio C Rovati, an esteemed inventor based in Monza, Italy, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 55 patents, his innovative work focuses on developing compounds that have therapeutic applications, particularly in treating various pathologies.

Latest Patents

Among his most recent inventions is (R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic acid, which serves as an EP4 receptor antagonist. This invention not only describes the compound itself but also advantageous methods for obtaining it, as well as pharmaceutical compositions containing this compound. Additionally, Rovati has developed a pharmaceutical combination that includes an EP4 antagonist and immune checkpoint inhibitors, aimed at enhancing treatment outcomes for tumors. This innovative combination, along with the polymorphic form A of the sodium salt of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)benzoate, emphasizes his commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Lucio C Rovati has had the opportunity to work with prominent companies such as Rottapharm Spa and Rotta Research Laboratorium S.p.a. His work in these organizations has been instrumental in advancing their pharmaceutical endeavors and expanding their research capabilities.

Collaborations

Collaboration has been a vital element of Rovati's career. He has worked alongside distinguished colleagues, including Francesco Makovec and Antonio Giordani. Together, they have driven innovative solutions and contributed to the pharmaceutical industry's evolution.

Conclusion

Lucio C Rovati's dedication to innovation and his substantive patent portfolio demonstrate his significant impact on pharmaceutical research and development. His latest inventions, career highlights, and collaborations reflect his unwavering commitment to advancing medical science, particularly in the fields of oncology and receptor antagonism. The contributions of inventors like Rovati continue to shape the future of healthcare and improve patient outcomes around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…